(Q36517429)

14 August 2017

Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma (English)

1 reference

14 August 2017

3

Esther Oliva

1 reference

14 August 2017

Ami P Vaidya

1

1 reference

14 August 2017

Neil S Horowitz

series ordinal

2

1 reference

14 August 2017

Elkan F Halpern

series ordinal

4

1 reference

14 August 2017

Linda R Duska

series ordinal

5

1 reference

14 August 2017

language of work or name

English

0 references

publication date

23 June 2006

1 reference

14 August 2017

1 reference

14 August 2017

103

1 reference

14 August 2017

2

1 reference

14 August 2017

684-687

1 reference

Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.009

Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.009

A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.009

Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.009

Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.009

Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.009

Postirradiation sarcoma of the gynecologic tract. A report of 13 cases and a discussion of the risk of radiation-induced gynecologic malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.009

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.009

Paclitaxel and platinum chemotherapy for malignant mixed müllerian tumors of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.009

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.009

Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.05.009

10.1016/J.YGYNO.2006.05.009

7 January 2021

Identifiers

DOI

1 reference

14 August 2017

1 reference